Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteers (Meningococcal Infection)”

53 trials

Showing 20 of 53 results

Testing effectiveness (Phase 2)Study completedNCT02640404
What this trial is testing

Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 224
Testing effectiveness (Phase 2)Study completedNCT00196963
What this trial is testing

Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 125
Large-scale testing (Phase 3)Study completedNCT03537508
What this trial is testing

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

Who this might be right for
Healthy Volunteers (Meningococcal Infection)
Sanofi Pasteur, a Sanofi Company 2,627
Post-approval studies (Phase 4)Study completedNCT04450498
What this trial is testing

Demonstrate Non-inferior Immunogenicity of Yuxi Walvax MPV ACYW® Vaccine in Healthy Subjects Aged 2-10 Years

Who this might be right for
Neisseria Meningitides Meningitis
Walvax Biotechnology Co., Ltd. 260
Early research (Phase 1)Study completedNCT00678652
What this trial is testing

Phase 1 Safety and Immunogenicity of Meningococcal Vaccine

Who this might be right for
Meningococcal Infection, Group B
U.S. Army Medical Research and Development Command 36
Not applicableEnded earlyNCT03549325
What this trial is testing

A Study Assessing Colonisation & Immunogenicity After Nasal Inoculation With N. Lactamica and Eradication on Day 4 or 14

Who this might be right for
Meningitis, Meningococcal
University Hospital Southampton NHS Foundation Trust 21
Large-scale testing (Phase 3)Study completedNCT04142242
What this trial is testing

Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier) in Study MET49

Who this might be right for
Meningococcal Infection (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 471
Testing effectiveness (Phase 2)Study completedNCT00427908
What this trial is testing

Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 613
Testing effectiveness (Phase 2)Study completedNCT00137917
What this trial is testing

Immunogenicity & Safety Study of a Meningococcal Serogroup B Vaccine Given in a 3 Dose Schedule to Healthy Adolescents Aged 12-18 Yrs

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 478
Large-scale testing (Phase 3)Study completedNCT03869866
What this trial is testing

Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) in Older Adults in Turkey and Lebanon

Who this might be right for
Healthy Volunteers (Meningococcal Infection)
Sanofi Pasteur, a Sanofi Company 290
Testing effectiveness (Phase 2)Study completedNCT00196950
What this trial is testing

Study to Evaluate Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 18-25 Years

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 50
Large-scale testing (Phase 3)Study completedNCT06228586
What this trial is testing

Study on a MenACYW Conjugate Vaccine Administered as a Single Dose in Participants Aged 12 Months and Older in Vietnam

Who this might be right for
Meningococcal InfectionHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 447
Large-scale testing (Phase 3)Study completedNCT01154088
What this trial is testing

Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Versus Mencevax™ ACWY in Healthy 18-25 Year Olds

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,170
Large-scale testing (Phase 3)Study completedNCT01086969
What this trial is testing

Meningococcal Vaccine, Menactra® in Healthy Subjects in India

Who this might be right for
Meningococcal InfectionMeningitis
Sanofi 300
Testing effectiveness (Phase 2)Study completedNCT01165242
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Versus Menactra® in Healthy Adolescents/Adults

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,013
Testing effectiveness (Phase 2)Active Not RecruitingNCT06647407
What this trial is testing

Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants

Who this might be right for
Meningococcal ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 750
Testing effectiveness (Phase 2)Study completedNCT00126945
What this trial is testing

Evaluate 4 Different Formulations of Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 125
Large-scale testing (Phase 3)Study completedNCT00514904
What this trial is testing

Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 2-10 Year Old Subjects

Who this might be right for
Infections, MeningococcalMeningococcal Vaccines
GlaxoSmithKline 1,504
Post-approval studies (Phase 4)Study completedNCT01766206
What this trial is testing

Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects From 2 Months to 55 Years of Age in the Republic of South Korea

Who this might be right for
Meningococcal Disease
GlaxoSmithKline 3,948
Large-scale testing (Phase 3)Study completedNCT01777308
What this trial is testing

Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary Vaccination

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 156
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation